Catalent, Inc. has acquired Micron Technologies, a global provider of particle size engineering technologies, expanding its drug delivery and development services and allowing the company to partner with pharma companies at the earliest stages of the drug development process. Micron’s portfolio of particle size reduction, micronization and milling technologies are used to help overcome bioavailability, stability and manufacturability challenges. Micron operates two facilities in Malvern, PA, and...